Comments
The US Food and Drug Administration (USFDA) has completed the audit of Dr Reddy’s Laboratories Ltd's Mexico unit.
"The audit of our Active Pharmaceutical Ingredients (API) Cuernavaca plant at Mexico by the USFDA has been completed with zero observations,’’ the Hyderabad-based Dr Reddy’s informed the bourses.
Dr Reddy’s shares ended up by 0.69 per cent at Rs 2,765.10 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.